These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24485781)

  • 1. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.
    Kuduk SD; Chang RK; Di Marco CN; Pitts DR; Greshock TJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Ray WJ
    J Med Chem; 2011 Jul; 54(13):4773-80. PubMed ID: 21682298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor.
    Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series.
    Kuduk SD; Chang RK; Di Marco CN; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1710-5. PubMed ID: 21324684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and optimization of selective azaindole amide M1 positive allosteric modulators.
    Davoren JE; O'Neil SV; Anderson DP; Brodney MA; Chenard L; Dlugolenski K; Edgerton JR; Green M; Garnsey M; Grimwood S; Harris AR; Kauffman GW; LaChapelle E; Lazzaro JT; Lee CW; Lotarski SM; Nason DM; Obach RS; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Yan J; Zhang L
    Bioorg Med Chem Lett; 2016 Jan; 26(2):650-655. PubMed ID: 26631313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Lim H; Jörg M; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    ACS Chem Neurosci; 2016 May; 7(5):647-61. PubMed ID: 26891194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological characterization of a series of novel diaryl amide M₁ antagonists.
    Poslusney MS; Sevel C; Utley TJ; Bridges TM; Morrison RD; Kett NR; Sheffler DJ; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6923-8. PubMed ID: 23062550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
    Bridges TM; Kennedy JP; Cho HP; Breininger ML; Gentry PR; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):558-62. PubMed ID: 20004578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M
    J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
    Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
    Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridine containing M(1) positive allosteric modulators with reduced plasma protein binding.
    Kuduk SD; Di Marco CN; Cofre V; Pitts DR; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger K; Thompson CD; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2010 Jan; 20(2):657-61. PubMed ID: 19962304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amides as carboxylic Acid surrogates for quinolizidinone-based m1 positive allosteric modulators.
    Kuduk SD; Chang RK; Greshock TJ; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT
    ACS Med Chem Lett; 2012 Dec; 3(12):1070-4. PubMed ID: 24900430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fused heterocyclic M1 positive allosteric modulators.
    Kuduk SD; Di Marco CN; Cofre V; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2011 May; 21(9):2769-72. PubMed ID: 21055928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Agonist Shift Assay Development for the Analysis of M
    Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD
    SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.
    Miller NR; Daniels RN; Lee D; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2174-7. PubMed ID: 20202841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M
    Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.